Filana Therapeutics
FLNA
61 hedge funds and large institutions have $67.2M invested in Filana Therapeutics in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 30 reducing their positions, and 15 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
58% more call options, than puts
Call options by funds: $136K | Put options by funds: $86K
21% more capital invested
Capital invested by funds: $55.4M → $67.2M (+$11.8M)
12% less funds holding
Funds holding: 69 → 61 (-8)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
67% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$1.42M |
| 2 |
SC
Sophrosyne Capital
New York
|
+$1.04M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$218K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$188K |
| 5 |
GS
Gagnon Securities
New York
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.44M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$801K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$362K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$296K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$293K |
FLNA Hedge Fund Activity: Q3 2013 in Review
61 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2013, worth a combined $67.2M — up 21% from $55.4M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of FLNA and 9 opened new positions — a net loss of 6 holders — while 30 trimmed existing stakes and 10 added.
The largest buyer was First Eagle Investment Management, adding an estimated $1.42M. The largest seller was Wellington Management Group, exiting entirely with an estimated $1.44M sold.
- 61 institutional investors held Filana Therapeutics (FLNA) as of Q3 2013, down from 69 in Q2 2013.
- Funds reported $67.2M of Filana Therapeutics stock for Q3 2013, up 21% quarter-over-quarter.
- 9 funds opened new Filana Therapeutics positions in Q3 2013 and 15 closed out, a net change of -6 holders.
- The largest Filana Therapeutics buyer in Q3 2013 was First Eagle Investment Management, an estimated $1.42M added.
- The largest Filana Therapeutics seller in Q3 2013 was Wellington Management Group, an estimated $1.44M sold.
Based on aggregated 13F filings for Q3 2013.